课题基金 / 基金详情

ACTG 329: NANDROLONE DECANOATE IN WOMEN W/ HIV ASSOCIATED WEIGHT LOSS

ACTG 329: NANDROLONE DECANOATE IN WOMEN W/ HIV ASSOCIATED WEIGHT LOSS
ACTG 329: 癸酸诺龙治疗与 HIV 相关的女性体重减轻
批准号:
6305553
负责人:
Kathleen Mulligan
金额:
$0.06万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-01 至 2000-11-30

项目摘要

项目成果

Kathleen Mulligan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a multicenter study designed to evaluate the safety and efficacy of nandrolone decanoate in women with HIV-associated weight loss. Secondary objectives include evaluation of the effects of nandrolone on body weight, sex hormones, quality of life, and activity level; and of the role, if any, of energy intake and sex hormones on the magnitude of response to therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
  • 批准号:
    9069958
  • 项目类别:
  • 资助金额:
    $61.32万
  • 财政年份:
    2013
  • 负责人:
    Kathleen Mulligan
  • 依托单位:
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
  • 批准号:
    8438137
  • 项目类别:
  • 资助金额:
    $62.36万
  • 财政年份:
    2013
  • 负责人:
    Kathleen Mulligan
  • 依托单位:
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
  • 批准号:
    9294153
  • 项目类别:
  • 资助金额:
    $61.68万
  • 财政年份:
    2013
  • 负责人:
    Kathleen Mulligan
  • 依托单位:
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
  • 批准号:
    8666804
  • 项目类别:
  • 资助金额:
    $60.44万
  • 财政年份:
    2013
  • 负责人:
    Kathleen Mulligan
  • 依托单位:
海外基金